Alper Can
Impact in
-
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Immunotherapy and Biomarkers
- Cancer Diagnosis and Treatment
- Lung Cancer Research Studies
-
- Brain Metastases and Treatment
Papers in
- Oncology 15
- Cancer Diagnosis and Treatment 4
- Inflammatory Biomarkers in Disease Prognosis 3
- Lung Cancer Research Studies 2
- Cancer Risks and Factors 2
-
- Gastric Cancer Management and Outcomes 3
- Prostate Cancer Treatment and Research 2
- Co-authors
- Ahmet Dirican (24 shared papers)Yüksel Küçükzeybek (24 shared papers)Lütfiye Demir (25 shared papers)Çiğdem Erten (22 shared papers)Mustafa Oktay Tarhan (20 shared papers)Işıl Somali (19 shared papers)Murat Akyol (20 shared papers)Ahmet Alacacıoğlu (15 shared papers)
- Journals
- Clinical & Experimental Metastasis (2 papers)Journal of Surgical Oncology (1 paper)Cancer Biomarkers (1 paper)The Breast Journal (1 paper)Environmental Toxicology and Pharmacology (1 paper)
- Partner nations
- TürkiyeGermanyKazakhstan
In The Last Decade
Alper Can
32 papers receiving 389 citations
Peers
Comparison fields: 5 of 60
- Oncology 193
- Pulmonary and Respiratory Medicine 110
- Gastroenterology 18
- Cancer Research 35
- Immunology 40
Countries citing papers authored by Alper Can
This map shows the geographic impact of Alper Can's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alper Can with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alper Can more than expected).
Fields of papers citing papers by Alper Can
This network shows the impact of papers produced by Alper Can. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alper Can. The network helps show where Alper Can may publish in the future.
Co-authors
The 25 scholars most cited alongside Alper Can, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 51 | |
| 2 | 2013 | 32 | |
| 3 | 2014 | 27 | |
| 4 | 2013 | 26 | |
| 5 | 2013 | 26 | |
| 6 | 2014 | 25 | |
| 7 | 2012 | 22 | |
| 8 | 2014 | 20 | |
| 9 | 2014 | 20 | |
| 10 | 2012 | 19 | |
| 11 | 2013 | 18 | |
| 12 | 2013 | 16 | |
| 13 | The association of hematologic parameters on the prognosis of patients with metastatic renal cell carcinoma. | 2013 | 16 |
| 14 | 2013 | 11 | |
| 15 | The maximum standardized uptake value of metastatic site in 18 F-FDG PET/CT predicts molecular subtypes and survival in metastatic breast cancer: An Izmir Oncology Group study. | 2017 | 8 |
| 16 | 2005 | 8 | |
| 17 | The relationship of insulin resistance and metabolic syndrome with known breast cancer prognostic factors in postmenopausal breast cancer patients. | 2014 | 6 |
| 18 | 1957 | 6 | |
| 19 | 2014 | 5 | |
| 20 | 2012 | 5 |
About Alper Can
Alper Can is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Rheumatology and Dermatology, having authored 32 papers that have together received 403 indexed citations. Recurring topics across this work include Cancer Diagnosis and Treatment (4 papers), Inflammatory Biomarkers in Disease Prognosis (3 papers), Gastric Cancer Management and Outcomes (3 papers), Computational Drug Discovery Methods (2 papers), Thyroid Cancer Diagnosis and Treatment (2 papers), Prostate Cancer Treatment and Research (2 papers), Lung Cancer Research Studies (2 papers) and Cancer Risks and Factors (2 papers). The work is most often cited by research in Oncology (193 citations), Pulmonary and Respiratory Medicine (110 citations), Gastroenterology (18 citations), Cancer Research (35 citations) and Immunology (40 citations). Alper Can has collaborated with scholars based in Türkiye, Germany and Kazakhstan. Frequent co-authors include Ahmet Dirican, Yüksel Küçükzeybek, Lütfiye Demir, Çiğdem Erten, Mustafa Oktay Tarhan, Işıl Somali, Murat Akyol, Ahmet Alacacıoğlu, İbrahim Vedat Bayoğlu and Suna Çokmert. Their work appears in journals such as Clinical & Experimental Metastasis, Journal of Surgical Oncology, Cancer Biomarkers, The Breast Journal and Environmental Toxicology and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.